Remote physical activity program for cancer survivors with and without diabetes

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to improve the quality of life for cancer survivors, particularly those experiencing cognitive difficulties after chemotherapy, by implementing a remote physical activity program. The program is based on Social Cognitive Theory and utilizes technology, such as wearable devices and smartphone applications, to encourage aerobic and resistance training. Participants will engage in a 12-week program designed to address the cognitive impairments associated with chemotherapy and the comorbidities of type 2 diabetes. The study will assess the effectiveness of this intervention in enhancing physical activity levels and overall health outcomes for cancer survivors.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. ≥18 years old
2. ability to speak/read English
3. ability to provide informed consent
4. underwent treatment within the last three years for a non-central nervous system-related cancer with said treatment having included chemotherapy
5. self-reported cognitive difficulties following cancer treatment
6. For CS+T2D: current T2D diagnosis as classified by a fasted blood glucose of ≥126 mg/dL, 2-hour oral glucose tolerance test of ≥200 mg/dL, HbA1c level of ≥6.5%, or use of medications to treat hyperglycemia (e.g., Metformin) or For CS: no current T2D diagnosis as classified by a fasted blood glucose \<100 mg/dL, 2-hour oral glucose tolerance test \<140 mg/dL, or HbA1c level of \<5.7%. Presence/absence of T2D to be confirmed preferentially via physician's documentation
7. own smartphone and/or computer with internet access
8. willing to participate in the 12-week remotely-delivered PA program

Exclusion Criteria:

1. reporting a Physical Activity Readiness Questionnaire (2017 PAR-Q) score that indicates PA may potentially be unsafe, unless the participant produces a signed doctor's note. We will define 2017 PAR-Q+ scores as indicating that PA may potentially be unsafe as responding "Yes" to any of the follow-up questions except \[1\] if the individual indicates that they have high blood pressure but subsequent responses indicate that they do not have problems keeping it under control and that their resting blood pressure is less than 160/90 mmHg, and \[2\] if the individual indicates that they have a metabolic condition but subsequent responses indicate that they do not have problems controlling their blood sugar levels, do not any experience signs or symptoms of hypoglycemia, and do not have any signs of symptoms of listed diabetes complications)
2. engaging in ≥75 min/week of vigorous-intensity PA, ≥150 min/week of moderate-intensity PA, or an equivalent combination of both over the last 3 months
3. currently a prisoner, pregnant, or planning to become pregnant during study.

Where it's running

• University of Oklahoma Health Sciences
  Oklahoma City, Oklahoma, United States Recruiting

Study contacts

• Principal investigator: Zachary C Pope, PhD — University of Oklahoma Health Sciences
• Study coordinator: Zachary C Pope, PhD
• Email: zachary-pope@ouhsc.edu
• Phone: 405-271-8001

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Need-based cancer survivorship program implementation

  This project tests a need-based survivorship program for adults who have finished cancer treatment to see if targeted screenings and referrals can help manage symptoms and weight concerns.

  Recruiting at 5 sites The University of Hong Kong · Hong Kong, Hong Kong and 4 other locations · NCT07830368

• AI-powered mobile app to help breast cancer patients manage chemotherapy symptoms

  A mobile app with artificial intelligence is being tested to see if it helps women with breast cancer manage chemotherapy symptoms and feel more confident in their care.

  Recruiting Ege University · Izmir, İzmir · NCT07826338

• Bridging psychosocial care after cancer treatment

  This study tests a routine digital distress screen plus a psycho-oncology navigation call to help cancer survivors access support after completing treatment.

  Recruiting University Hospital, Basel, Switzerland · Basel · NCT07672314

• Hematologic cancer survivors after stem cell transplant try a personalized care plan

  This study tests a personalized Survivorship Care Plan for people with hematologic cancer who have undergone a stem cell transplant to see if it’s feasible within the Italian health system.

  Recruiting Azienda USL Reggio Emilia - IRCCS · Reggio Emilia · NCT07579065

• Family-building support for young women after cancer

  This pilot tests whether a nurse-delivered four-session videoconference program helps young female cancer survivors make informed, values-based decisions about having children.

  Recruiting Duke University · Durham, North Carolina · NCT07471685

• DA-020 topically for chemotherapy-induced hair loss

  This study tests DA-020 (a topical alpha-1 agonist) to see if it can reduce hair loss in people with breast cancer receiving certain chemotherapies.

  Recruiting Phase 1/2 Applied Biology, Inc. · Manaus and 1 other locations · NCT07397325

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.